Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
about
Perfusion magnetic resonance imaging: a comprehensive update on principles and techniquesImproving tumour heterogeneity MRI assessment with histograms.Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsPitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer's disease and other neurological disorders.A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.Increased hippocampal blood volume and normal blood flow in schizophrenia.MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.Advances in neuro-oncology imaging.Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.Current Clinical Brain Tumor ImagingDifferentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imagingAmino acid PET and MR perfusion imaging in brain tumours.Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysisMRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatmentTechnical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma.Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.Pseudoprogression as an adverse event of glioblastoma therapy.Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and TemozolomiTumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.Conventional and advanced magnetic resonance imaging in patients with high grade glioma.Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
P2860
Q27012911-C94F0B47-35DC-4ED4-93FC-EACC6E24A12AQ27693208-C15EC546-F0AC-40C3-93BF-3EB0C39574B9Q28066044-A260A528-4A05-43B8-AF03-6E206E11599AQ30907831-966053D6-2121-494B-BD48-B50F4F92F5FAQ30985703-0A846C6F-D90D-4CCB-8C1F-BA86DFB6E891Q31130812-FD087931-EF39-446C-9237-DF75358324D6Q34389144-21D08E11-9871-4399-9D05-0C01EE750B14Q35629893-4BAA5389-5B70-468B-91F8-CEF006DB942DQ36097886-026DC6F1-8B71-4B27-B32D-B71721EA5ADEQ36339461-FEA4F747-E314-4163-A03F-B3CD691F5960Q36361484-44AE02AD-8B1C-4FAB-AF31-5213D1E66161Q36367172-8B8DF905-AAC7-4D99-BE79-9562EE89A6F3Q36953470-4846E39C-D96C-4C4A-9300-B8FB2553142AQ38691946-EEF1E390-AFC4-491C-98CB-34F21534E5B6Q38884741-55DCA3BE-E85C-46FB-9118-2E4C7752A301Q39312420-8A0F0171-1E78-44B4-816E-6550D7CE5E79Q41090550-245D9210-3584-40C6-B4B6-2D879AD47989Q41654869-5DECFA67-105F-4966-A688-A99E01040327Q42386456-95C7D979-5EE2-45CB-9F65-29130B00A73EQ43946394-5B2FBB9B-E8A3-4595-9A64-9F32059E28F6Q47164037-500CF640-ACDE-4772-A733-1B39BBB8C0D7Q47406548-E28329F7-FEDB-40D2-9468-0AB9CBCA84FAQ47825877-DAE1B177-2A47-44BE-9DDD-5D15CEDDEC2FQ48156027-B41A2015-BC14-42E1-B223-09C658A19A88Q52562075-25091095-5997-4527-BAD8-095061D2E2F8Q57177114-3B4978BD-EDD1-49A9-8113-51489F10EEFF
P2860
Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@ast
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@en
type
label
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@ast
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@en
prefLabel
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@ast
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@en
P2093
P2860
P356
P1433
P1476
Pseudoprogression in patients ...... contrast perfusion MR imaging.
@en
P2093
Dae Chul Suh
Geon-Ho Jahng
Ho Sung Kim
Sang Joon Kim
Young Jun Choi
P2860
P304
P356
10.1177/0284185112474916
P407
P577
2013-04-30T00:00:00Z